(Q33479195)
Statements
Phase II trial of cisplatin as second-line chemotherapy in patients with advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group study (English)
J T Thigpen
J A Blessing
L D Lagasse
P J DiSaia
scientific article